Eli Lilly signals entry into aesthetics market with plans to acquire skin, body and hair treatments

Eli Lilly is indicating an interest in expanding into the aesthetics sector, according to a recent job posting. The company appears to be seeking opportunities to add products that address skin aging, body shaping and hair conditions.

The posting suggests that Lilly may look to acquire existing drugs or development programs that fit these therapeutic areas. No specific candidates or deals have been disclosed.

If pursued, this move would broaden Lilly's portfolio beyond its traditional focus on chronic diseases and could open new revenue streams in the growing cosmetic and dermatology markets.